Tyrosine kinase inhibitors (TKIs)
Drug timelines are a Plus or Pro feature.
4 regulatory and trial events tracked for Tyrosine kinase inhibitors (TKIs), covering 2015-09-02 to 2026-04-27. Get the full timeline:
Most recent: Clinical Trial Update: Discontinuation of TyrosIne Kinase Inhibitors (TKI) in Chronic Myeloid Leukemia (CML) and Impact on the Immune System [Phase 3]